Shares of Prothena Corporation PRTA plummeted 53.5% year to date compared with the industry’s decline of 0.6%. The recent ...

The move helps in expediting the enrolment process for central nervous system, vaccine, as well as specialty trials.

Summit Therapeutics nears a $15B AstraZeneca deal for ivonescimab, targeting a $90B market. See more on the potential and ...

When surgeons dissect tissue to remove a tumor or make a repair, they must work cautiously, relying on electrophysical ...

Brazil is experiencing a regulatory revolution that is fundamentally transforming its medical device clinical trial landscape ...

New research reveals that combining lurbinectedin with atezolizumab significantly improves survival rates for patients with ...

In recognition of its innovation, client-focused delivery, and global impact, Novotech has been awarded the 2025 Global Biotechnology Contract Research Organization (CRO) Company of the Year by Frost ...

After decades of setbacks, Alzheimer’s drug development is expanding beyond anti-amyloids, with a record number of trials and ...

Recognized for its biotech-first focus, innovation in clinical trial delivery, and best-in-class client experience, Novotech ...

The GCAptAIN study did not meet its primary endpoint of sustained remission at Week 52 in adults with newly diagnosed or relapsing GCA1 ...

India has reached the 50 per cent enrolment mark in its first phase III clinical trial for the indigenous tetravalent dengue ...

For the past six years, it has ranked among the world’s top 20 medical schools. Read more at straitstimes.com. Read more at ...